State of the Art of Medicinal Chemistry in Portugal
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (24 May 2024) | Viewed by 6866
Special Issue Editors
Interests: organic chemistry; tetrazoles, thiazoles and thiadiazoles; nitrogen ligands; organocatalysis; metal catalysis; selective chelators for metals on biological medium; leads for cancer chemotherapy
Special Issues, Collections and Topics in MDPI journals
Interests: chemical toxicology; drug design; MS-based OMICS; biomarkers; organic synthesis; epigenetic drugs; HK2 inhibitors; drug repurposing
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Pharmaceutical research in Portugal has for decades been an extremely dynamic area embraced by a multidisciplinary panorama that has allowed it to achieve sustainable development. The international recognition of this research is not limited to the academic environment, with several successful multinational pharmaceutical companies currently intensifying their activities in Portugal. Pharmaceutical researchers spread across the country and in several international research centers are developing their work and dedicating themselves diligently to projects that aim at a practical application.
The topics of pharmaceutical research actually being explored by the country's scientific community are quite numerous. These include, with great emphasis, research aimed at fighting cancer and neurodegenerative and infectious diseases.
This Special Issue, called “State of the Art of Medicinal Chemistry in Portugal”, aims to compile recent works of proven impact and led by Portuguese researchers in the field of medicinal chemistry. It is particularly hoped that this disclosure can serve as a source of inspiration for other scientific communities and scientists at the beginning of their careers.
Dr. Luís M. T. Frija
Prof. Dr. Maria Matilde Soares Duarte Marques
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- medicinal chemistry in Portugal
- anticancer research and therapies
- neurodegenerative diseases
- infectious diseases
- drug design and drug discovery
- chemical biology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.